Inventiva - ADR
:IVA 4:00:00 PM EDT
| Market Cap (Intraday) | 707.20M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $5.34 |
| 50-Day MA | $5.17 |
| 200-Day MA | $3.57 |
Inventiva - ADR Stock, :IVA
50, rue de Dijon, Daix, Bourgogne-Franche-Comte 21121
France
Phone: +33.3.80.44.75.00
Number of Employees: 123
Description
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Fr�©d�©ric Cren on October 27, 2011 and is headquartered in Daix, France.